PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
AACT 109 Target Target A1AT 329 1 0.01 -0.99 0.01 0.70
ANGPTL4 289 Target Target A1AT 329 1 0.00 -1.00 0.00 0.69
ERK1 18,374 Target Target A1AT 329 1 0.00 -1.00 0.00 0.56
BNP 6,842 Target Target A1AT 329 1 0.00 -1.00 0.00 0.59
Alpha (Prolastin)- FDA 13 Drug Target A1AT 329 1 0.02 -0.96 0.08 0.73
Colon Cancer 30,064 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Non Small Cell Lung Cancer 28,563 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Cervical Cancer 28,286 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Osteoarthritis 36,287 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Fibromyalgia 6,837 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.59
Anxiety 113,510 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.52
Tuberculosis 146,217 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.51
Diarrhea 51,986 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.54
Kidney Diseases 4,651 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.60
Multiple Myeloma 24,594 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.56
Influenza 67,933 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.53
Analgesia 44,857 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.59
Diabetes 332,602 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.55
APOE 12,771 Target Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.63
Obesity 138,233 Disease Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.57
Epidermal Growth Factor Receptor 24,772 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79
Glucocorticoid Receptor 10,306 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
CD4 112,219 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Calmodulin 25,240 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
Catechol O-Methyltransferase 2,877 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.64
ERK1 18,374 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.59
Adiponectin 11,994 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Phospholipase A2 13,400 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Analgesia 44,857 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Seizure 44,685 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Diabetes 332,602 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.53
Cancer 1,053,491 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Anxiety 113,510 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Infection 766,637 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Eating Disorders 9,000 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Arthritis 128,324 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Obsessive Compulsive Disorder 8,508 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Headache 50,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Attention Deficit Hyperactivity Disorder 14,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Rheumatoid Arthritis 78,952 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.56
744.1 22 Target Target 464.1 19 1 0.05 -0.95 0.05 0.83
Eotaxin 2,457 Target Target 464.1 19 1 0.00 -0.97 0.05 0.66
Diabetes 332,602 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.55
Carcinoma 433,099 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.54
Prostate Cancer 71,064 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Acute Promyelocytic Leukemia 4,780 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.65
Renal Failure 73,993 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Carcinoma 433,099 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.52
Dehydration 21,928 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.59